Publications by authors named "Patricia Howell Monteiro"

Article Synopsis
  • Tuberculosis (TB) is a major global health concern, causing significant illness and death, and can manifest in various forms, including pulmonary (PTB) and extrapulmonary (EPTB) diseases.
  • One rare hematological complication associated with TB is immune thrombocytopenic purpura (ITP), which was observed in a case involving a 22-year-old woman with ganglionic tuberculosis.
  • Treatment of this case involved a combination of intravenous immunoglobulin, high-dose corticosteroids, and anti-tubercular therapy, leading to positive results.
View Article and Find Full Text PDF

Unlabelled: Syphilis, a disease caused by the bacteria , has a multitude of clinical manifestations and is classified into primary syphilis, secondary syphilis and tertiary syphilis, based on clinical presentations and the time elapsed since the primary infection. The secondary stage of the disease can affect multiple organs and systems, and some of these involvements may be general and non-specific, justifying its name as 'the great imitator'. We present a case of a 30-year-old woman with a history of painful neck lymph nodes with progressive enlargement, persistent headache, weight loss, myalgia and alopecia.

View Article and Find Full Text PDF

Severe coronavirus disease 2019 (COVID-19) is known to manifest in two phases, with a potential worsening in the second week. The pathophysiology of the first phase is expected to be heavily influenced by viral replication while the second phase is thought to be primarily characterized by systemic inflammation. We present the case of a 42-year-old man hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with a history of Philadelphia-positive chronic myeloid leukemia, diagnosed seven months earlier, proposed to bone marrow allotransplantation after refractory imatinib and dasatinib treatment.

View Article and Find Full Text PDF

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients with cancer show worse outcomes compared with patients without cancer. The humoral immune response (HIR) of patients with cancer against SARS-CoV-2 is not well characterized. To better understand it, we conducted a serological study of hospitalized patients with cancer infected with SARS-CoV-2.

View Article and Find Full Text PDF